Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-05-06
2008-05-06
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S130000
Reexamination Certificate
active
07368446
ABSTRACT:
The present invention relates to the compound of formulawhich is 4-hydroxy-4-methyl-piperidine-1-carboxylic acid(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide, and to pharmaceutically acceptable acid addition salts thereof. It has been found that the compound is useful for the treatment or prevention of Alzheimer's disease, Parkinson's disease, Huntington's disease, neuroprotection, schizophrenia, anxiety, pain, respiration deficits, depression, ADHD (attention deficit hyper-activity disorder), drug addiction to amphetamines, cocaine, opioids, ethanol, nicotine, or cannabinoids, or for the treatment of asthma, allergic responses, hypoxia, ischemia, seizure, substance abuse, or for use as muscle relaxants, antipsychotics, antiepileptics, anticonvulsants and cardioprotective agents.
REFERENCES:
patent: 3725428 (1973-04-01), Janiak
patent: 4028374 (1977-06-01), Pelosi, Jr. et al.
patent: 5099021 (1992-03-01), Worther et al.
patent: 6878720 (2005-09-01), Altmann et al.
patent: 1 953 149 (1970-05-01), None
patent: 0 199 400 (1986-10-01), None
patent: 295 656 (1988-12-01), None
patent: 0343893 (1989-11-01), None
patent: 0404440 (1990-12-01), None
patent: 427 963 (1991-05-01), None
patent: 0604657 (1994-07-01), None
patent: 2 753 970 (1998-04-01), None
patent: 1 345 552 (1974-01-01), None
patent: 1 538 822 (1979-01-01), None
patent: WO 99/37630 (1990-01-01), None
patent: WO 99/24035 (1999-05-01), None
patent: WO 00/18767 (2000-04-01), None
patent: WO 00/27819 (2000-05-01), None
patent: WO 01/19360 (2000-09-01), None
patent: WO 01/87786 (2001-12-01), None
patent: WO 03/049741 (2003-06-01), None
patent: WO 03/053946 (2003-07-01), None
Poulsen, et al., Bioorganic & Medicinal Chemistry, vol. 6 (1998) pp. 619-641.
Müller, et al., Bioorganic & Medicinal Chemistry, vol. 6, (1998) pp. 707-719.
Kim, et al., J. Med. Chem., (1998), vol. 41, pp. 2835-2845.
Li, et al., J. Med. Chem., (1998), vol. 41, pp. 3186-3201.
Baraldi, et al., J. Med. Chem., (1998), vol. 41, pp. 2126-2133.
Li, et al., J. Med. Chem., (1999), vol. 42, pp. 706-721.
Baraldi, et al., J. Med. Chem., (1996), vol. 39, pp. 1164-1171.
Colotta, et al., Arch. Pharm. Med. Chem., vol. 332, pp. 39-41 (1999).
Auchampach, et al., Am. J. Physiol. vol. 276, H1113-1116 (1999).
Naunyn-Schmiedeberg, Arch. Pharmacol. vol. 362, pp. 375-381 (2000).
Patent Abstracts of Japan, vol. 1999, No. 10, JP 11 130761a.
Pandeya, S. N. et al:, Indian Drugs (1985), 23(3), 146-51 XP0080000199.
Daidone, G. et al., vol. 44, No. 5 (1989), pp. 465-473, XP001053114.
The Merck Index 12th Ed. (1996) p. 506.
Abstract corresponding to FR 2 753 970 (B6), 1998.
Flohr Alexander
Moreau Jean-Luc
Poli Sonia Maria
Riemer Claus
Steward Lucinda
Anderson Rebecca
Hoffmann-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
4-hydroxy-4-methyl-piperidine-1-carboxylic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-hydroxy-4-methyl-piperidine-1-carboxylic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-hydroxy-4-methyl-piperidine-1-carboxylic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2805408